3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)

作者：Padmanee Sharma, Bernard Escudier, David F. McDermott, Saby George, Hans J. Hammers, S. Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, L. Xu, Ian M. Waxman, Robert J. Motzer · 发表于：European Journal of Cancer · 年份：2015 · DOI：10.1016/s0959-8049(16)31926-8 · 被引用次数：6 · 研究领域：Renal cell carcinoma treatment、Pancreatic and Hepatic Oncology Research、Renal and related cancers